NCT01940978View on ClinicalTrials.gov

A Study of Combination Therapy in Children With ADHD

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

ADHDAttention Deficit Hyperactivity DisorderAttention Deficit Disorder With HyperactivityMental Disorders Diagnosed in ChildhoodAttention Deficit and Disruptive Behavior Disorders

Interventions

DRUG

Methylphenidate ER

Watson generic, starting dose 18mg QD

DRUG

Cyproheptadine

cyproheptadine hydrochloride

Trial Locations (1)

91403

SMRI (Schuster Medical Research Institute), Van Nuys

All Listed Sponsors

lead

Douglas Sears

INDIV

NCT01940978 - A Study of Combination Therapy in Children With ADHD | Biotech Hunter | Biotech Hunter